Blood-brain barrier (BBB) evidence

Peptide

ATLPC0017661

Measured material

Peptide backbone

Endpoint

Blood-brain barrier (BBB)

ADMET domain

Distribution / Barrier

Value

1.85 x 10^-4 mL/g/min

Measurement type

Unidirectional influx (Kin / PS product) — Blood-to-brain unidirectional influx rate — Kin / permeability-surface-area product (mL·min⁻¹·g⁻¹), typically in situ brain perfusion.

Evidence role

Comparable: structured measurement intended for within-endpoint comparison when assay context matches

Assay / model

Intravenous injection (multiple time regression) · blood-brain barrier

Condition

Kin

Scientific source

DOI: 10.1016/j.molmet.2018.09.007

Source: Brainpeps

Open DOI

Blood-brain barrier (BBB) evidence

Developability

Resources

Measurement